Latest Meeting Info:

Towards Rabies Elimination in Asia-Pacific - From Theory to Practice

Topic: From endemic rabies to elimination of dog-mediated rabies by implementation of sustained mass dog vaccination campaigns
Dr. Katinka de Balogh, Food & Agriculture Organization, Italy

 IABS Success Stories

 

Discover IABS success stories

 

 See every IABS conferences since year 2000

 

If you would like to join IABS, click here to see the online and offline application form.

Upcoming events and News

September 25-26, 2019 - Bangkok, Thailand

Towards Rabies Elimination in Asia-Pacific – From Theory to Practice

Register Here

Registration and information about the meeting here

Use the buttons below if you would like to share this info :
Read more ...

October 22, 2019 - Paul-Ehrlich-Institut, Langen, Germany

Quality of Challenge Agent
An IABS-EU Meeting

SAVE THE DATE

Use the buttons below if you would like to share this info :
Read more ...

November 13-14, 2019 - Het Pand, University of Ghent, Belgium

2nd Conference on Next Generation Sequencing
for Adventitious Virus Detection in
Human and Veterinary Biologics

An IABS-EU Meeting

Register Here!

Registration and information about the meeting here

Use the buttons below if you would like to share this info :
Read more ...

December 3-4, 2019 - Bangkok, Thailand

Animal Testing for Vaccines
Implementing Replacement, Reduction and Refinement:

Challenges and Priorities

Register Here

Registration and information about the meeting here



Use the buttons below if you would like to share this info :
Read more ...

February 6-7, 2020 - Pembroke College - Oxford, United Kingdom

3rd Human Challenge Trials in Vaccine Development

SAVE THE DATE

 More information about this meeting soon....

Use the buttons below if you would like to share this info :

December 2-3, 2019 - Rockville, Maryland

2nd Setting Specifications for Biological Products: A Pathway to Harmonization

SAVE THE DATE

 

This 2nd meeting will expand on considerations discussed in a September 2013 workshop and include participants from biotechnology medicinal products, vaccines, and gene & cell therapies. The goals of this workshop will be to explore the implications from lack of worldwide agreement on principles and practices in setting product specifications and discuss a pathway towards harmonization. Business and regulatory strategies for managing worldwide specifications will be reviewed and challenged. Data sources and statistical approaches for setting limits which reflect product quality will be discussed. The meeting will bring the right experts together to discuss the issues and through roundtables attempt to reach conclusions that will be valuable globally to public health.

More information coming soon....

Use the buttons below if you would like to share this info :

In Brief

  • Welcome message from the President

    Dear Colleagues

    It is a pleasure to announce another milestone in the distinguished history of the International Alliance for Biological Standardization (IABS); the hiring of an Executive Director. For the first time in the 64-year history of IABS, the Board of Directors established an executive position to help oversee IABS operations.

    I am pleased to announce that on March 1, 2019 Mr. Phillippe Sabot started his tenure as the first IABS Executive Director.

    read more

  • NICEATM / IABS 3Rs meeting - NIH, Bethesda, Maryland

    Implementing non-animal approaches to human and veterinary vaccine testing:
    Achieving scientific and regulatory success for rabies and beyond

    View the meeting webpage Here

     

  • IABS Presentation to the U.S. Veterinary Biologics Training Program

    IABS Presentation to the U.S. Veterinary Biologics Training Program

    In May 2019, an overview of IABS’ mission and activities was presented at the U.S. Veterinary Biologics Training Program. The training program is co-sponsored by the USDA APHIS Center for Veterinary Biologics, the USDA APHIS National Veterinary Services Laboratories and the ISU College of Veterinary Medicine’s Institute for International Cooperation in Animal Biologics (IICAB). 

    Read more

  • Diagnostics in the Veterinary Field Workshop: Conclusions & Recommendations

    Diagnostics in the Veterinary Field: Conclusions & Recommendations

  • 1

Latest news

  • View the speaker slides from the 3Rs meeting, NIH, Bethesda : folder click here

    View the meeting webpage Here

     

  • IABS Presentation to the U.S. Veterinary Biologics Training Program

    In May 2018, an overview of IABS’ mission and activities was presented at the U.S. Veterinary Biologics Training Program. The training program is co-sponsored by the USDA APHIS Center for Veterinary Biologics, the USDA APHIS National Veterinary Services Laboratories and the ISU College of Veterinary Medicine’s Institute for International Cooperation in Animal Biologics (IICAB).  The IICAB was founded in 1995 by the USDA Animal and Plant Health Inspection Service and Iowa State University. In June 1998, the IICAB received designation as a component of the World Organization for Animal Health (OIE) Collaborating Centre for the Diagnosis of Animal Diseases and Vaccine Evaluation in the Americas. The designation is shared with the USDA APHIS National Veterinary Services Laboratories (NVSL) and Center for Veterinary Biologics (CVB). 

    The first Veterinary Biologics Training Program was held in June 1996 at the ISU College of Veterinary Medicine. The training program has been offered each year since then. More than 2600 individuals have attended the program including over 740 international participants from 90 different countries. More than 150 participants attended in 2018.  The program is known worldwide as a premier training program in immunology and veterinary vaccines. Many individuals who have participated in the training continue to be actively involved with veterinary biologics issues and activities world-wide.

    Training Program participants were keenly interested in IABS and had many questions.  Complimentary IABS Membership for 2018-2019 was offered to participants.  IABS is looking forward to some of the new members attending upcoming conferences and workshops and becoming more actively involved with our organization.

    Respectfully submitted,

    Rick Hill, IABS Communication Committee Chair

  • Join CASSS for the first CASSS Cell & Gene Therapy Products meeting on July 10-12, 2018 at the Bethesda North Marriott Hotel & Conference Center, Rockville, MD.

     

    We are very pleased to be launching the Symposium this July, continuing CASSS’ commitment to driving science forward and pushing through pre-conceived notions.

    Learn more at http://www.casss.org/?page=CGTP1801

  • IABS “3R” Conferences Highlighted in Presentation at the 10th World Congress on Alternatives and Animal Use in the Life Sciences.

    August 24, 2017, an overview of IABS’ “3R” Conferences, Symposia and Workshops was included in a presentation at the vaccine session at the 10th World Congress on Alternatives and Animal Use in the Life Sciences in Seattle Washington (See Summary Slide below).  The World Congress are periodic scientific meetings with emphasis on the latest technologies for reduction and replacement of animals and innovations in approaches to ethics, animal welfare and public policy.   Interestingly, the World Congress’ first meeting was in 1993, within one year of the IABS’s first Langen Symposium.  The 11th World Congress is scheduled for 2020 in the Netherlands. 

    In general, World Congress participants were aware of IABS’ leadership in the “3R” and Animal “Alternatives” arena and several inquired about the status of future IABS conferences.   The meeting presented an opportunity to discuss IABS overall, but also the organizations strategic priority to host “3R” related meetings by the North American and European Affiliates.

    Respectfully submitted,

    Rick Hill, IABS Communication Committee Chair

     

  • IABS is pleased to announce a valuable new book written by Board Member Dr. Rebecca Sheets titled Fundamentals of Biologicals Regulation:  Vaccines & Biotechnology Medicines. Dec. 2017, published by Elsevier’s imprint Academic Press.

    For more information, please see https://www.elsevier.com/books/fundamentals-of-biologicals-regulation/sheets/978-0-12-809290-3

  • 1
  • 2
  • 3
  • 4
  • 5

IABS-EU Heads Work Package in new IMI project: VAC2VAC

VAV2VAC is a wide-ranging collaborative research project funded by IMI2 which aims to develop and validate quality testing approaches for both human and veterinary vaccines using non-animal methods. The initiative that started on 1 March 2016 aims to provide the data to support the "Consistency Approach" for quality control of established vaccines, where current quality control approaches are often relying on in vivo methods.

VAC2VAC is a public-private consortium of twenty partners, involving experts from veterinary and human vaccine industry in a partnership with official medicines control laboratories, academia, translational research organisations, and vaccinology alliances. To achieve their goal, the project partners will develop, optimise and evaluate physico-chemical and immunochemical methods, cell-based and other assays for routine batch quality, safety and efficacy testing of vaccines. This will be done in collaboration and consultation with regulatory agencies. The ultimate goal of the project is to develop tests and approaches that will allow acceptance of the "Consistency Approach" for established vaccines by the regulatory agencies and thereby significantly reducing in the future the use of animals for batch testing in routine vaccine production.

Learn More

Press Release…

ZAPI

About ZAPI - The new Zoonoses Anticipation and Preparedness Initiative (ZAPI), part of the Innovative Medicines Initiative (IMI) public-private partnership, aims to enable swift response to major new infectious disease threats in Europe and throughout the world by designing new manufacturing processes (up to large scale) for delivering effective control tools (vaccines, antibodies/antibody-like molecules) against (re-)emerging zoonotic diseases with pandemic potential within a few months after the occurrence of first cases…

Learn more

 


IABS-EU is officially recognized by French authorities as a nonprofit organization.

You will be hearing more about IABS-EU in the months ahead.

Founding Members :

Read more:

International Alliance for Biological Standardization


Twitter Feed

Register for IABS #RabiesElimination conference. Bangkok. December 3-4, 2019 Topic: Global Strategic Plan for the… https://t.co/4Ead5Fd0dS
IABS #diagnosticsveterinary workshop. Topic: Survival of viral pathogens in animal feed ingredients under transboun… https://t.co/Mpx7gHZZ6V
Follow IABS_global on Twitter

Contact Info

IABS, Rue de la Vallée, 3
CH-1204 Geneva

Switzerland
+ 41 22 301 10 36
+ 41 22 301 10 37
This email address is being protected from spambots. You need JavaScript enabled to view it.